Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 11 studies | 22% ± 7% | |
lung | 10 studies | 32% ± 15% | |
intestine | 8 studies | 28% ± 13% | |
kidney | 7 studies | 24% ± 5% | |
brain | 5 studies | 22% ± 4% | |
eye | 4 studies | 21% ± 6% | |
uterus | 4 studies | 34% ± 17% | |
liver | 4 studies | 28% ± 12% | |
bone marrow | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 10470.16 | 459 / 459 | 100% | 73.09 | 1116 / 1118 |
intestine | 100% | 12067.08 | 966 / 966 | 100% | 82.18 | 525 / 527 |
prostate | 100% | 8773.88 | 244 / 245 | 100% | 116.59 | 502 / 502 |
uterus | 100% | 10925.66 | 170 / 170 | 100% | 101.28 | 457 / 459 |
kidney | 100% | 7028.01 | 89 / 89 | 100% | 93.44 | 897 / 901 |
ovary | 100% | 8786.34 | 180 / 180 | 99% | 54.94 | 427 / 430 |
bladder | 100% | 14111.67 | 21 / 21 | 99% | 97.98 | 500 / 504 |
esophagus | 100% | 15665.93 | 1439 / 1445 | 99% | 66.79 | 182 / 183 |
lung | 99% | 7051.09 | 572 / 578 | 100% | 98.30 | 1155 / 1155 |
liver | 99% | 7419.50 | 224 / 226 | 100% | 110.44 | 405 / 406 |
thymus | 100% | 6126.60 | 650 / 653 | 99% | 76.33 | 600 / 605 |
stomach | 98% | 7059.46 | 353 / 359 | 99% | 71.32 | 284 / 286 |
skin | 98% | 8065.26 | 1772 / 1809 | 98% | 84.57 | 462 / 472 |
adrenal gland | 97% | 6121.13 | 250 / 258 | 97% | 55.50 | 222 / 230 |
brain | 92% | 3686.56 | 2421 / 2642 | 100% | 93.50 | 705 / 705 |
pancreas | 79% | 2244.48 | 260 / 328 | 99% | 69.45 | 176 / 178 |
adipose | 100% | 11760.13 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 16985.50 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 59.33 | 29 / 29 |
spleen | 100% | 4469.27 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 113.97 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 66.40 | 1 / 1 |
muscle | 95% | 4309.86 | 766 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 51.60 | 76 / 80 |
heart | 93% | 5407.56 | 798 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 30% | 1604.51 | 278 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045777 | Biological process | positive regulation of blood pressure |
GO_0046294 | Biological process | formaldehyde catabolic process |
GO_0051409 | Biological process | response to nitrosative stress |
GO_0010430 | Biological process | fatty acid omega-oxidation |
GO_0001523 | Biological process | retinoid metabolic process |
GO_0051775 | Biological process | response to redox state |
GO_0003016 | Biological process | respiratory system process |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0005739 | Cellular component | mitochondrion |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0106322 | Molecular function | S-(hydroxymethyl)glutathione dehydrogenase (NAD+) activity |
GO_0009055 | Molecular function | electron transfer activity |
GO_0004024 | Molecular function | alcohol dehydrogenase (NAD+) activity, zinc-dependent |
GO_0042802 | Molecular function | identical protein binding |
GO_0106321 | Molecular function | S-(hydroxymethyl)glutathione dehydrogenase (NADP+) activity |
GO_0051903 | Molecular function | S-(hydroxymethyl)glutathione dehydrogenase [NAD(P)+] activity |
GO_0005504 | Molecular function | fatty acid binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0018467 | Molecular function | formaldehyde dehydrogenase (NAD+) activity |
Gene name | ADH5 |
Protein name | Alcohol dehydrogenase class-3 (Alcohol dehydrogenase class-III) Alcohol dehydrogenase 5 (EC 1.1.1.1) S-(hydroxymethyl)glutathione dehydrogenase (EC 1.1.1.284) Alcohol dehydrogenase class-3 Alcohol dehydrogenase 5 (class III), chi polypeptide Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase 5) (Alcohol dehydrogenase class chi chain) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284) |
Synonyms | FDH hCG_41483 HEL-S-60p ADHX |
Description | FUNCTION: Catalyzes the oxidation of long-chain primary alcohols and the oxidation of S-(hydroxymethyl) glutathione . Also oxidizes long chain omega-hydroxy fatty acids, such as 20-HETE, producing both the intermediate aldehyde, 20-oxoarachidonate and the end product, a dicarboxylic acid, (5Z,8Z,11Z,14Z)-eicosatetraenedioate . Class-III ADH is remarkably ineffective in oxidizing ethanol . Required for clearance of cellular formaldehyde, a cytotoxic and carcinogenic metabolite that induces DNA damage . . |
Accessions | D6R9G2 D6RAY0 ENST00000512659.5 D6RFE4 ENST00000296412.14 ENST00000505652.1 H0YAG8 Q6FI45 ENST00000502590.5 Q9H1A0 P11766 Q6IRT1 ENST00000503130.5 ENST00000626055.2 |